Write an exhaustive analysis focusing on biological experimental conclusions to learn how the diseases are doing on a Gene Ontology (GO) enrichment dataset for CU or EC, taking the main ideas for all the dataset without specifying in each of them. The dataset includes enrichment information for the 15 most enriched ontologies in the dataset. Each entry in the dataset has the following attributes:

Ontology: The KEGG identifier.
Sample: Sample used for enrichment analysis.
Description: Description of the KEGG term.
Disease: Disease studied.
Group_1: First group for comparison.
Group_2: Second group for comparison.
ea_value: Enrichment value.
metabolic_domain: The first level hierarchy pathway in the KEGG hierarchy.
metabolic_subdomain: Second level of hierarchy pathway in the KEGG hierarchy.

So here are the gene ontologies to analyze:\n\n- Ontology: ec00901 | Sample: FECAL | Description: Indole alkaloid biosynthesis | Disease: CU | Group_1: control | Group_2: CU.3.meses | ea_value: 60.8849325337331 | metabolic_domain: Metabolism | metabolic_subdomain:  Biosynthesis of other secondary metabolites\n- Ontology: ec00073 | Sample: FECAL | Description: Cutin, suberine and wax biosynthesis | Disease: CU | Group_1: control | Group_2: CU.debut | ea_value: 6.61620234604106 | metabolic_domain: Metabolism | metabolic_subdomain:  Lipid metabolism\n- Ontology: ec00140 | Sample: FECAL | Description: Steroid hormone biosynthesis | Disease: CU | Group_1: control | Group_2: CU.3.meses | ea_value: 6.13392977018953 | metabolic_domain: Metabolism | metabolic_subdomain:  Lipid metabolism\n- Ontology: ec00140 | Sample: FECAL | Description: Steroid hormone biosynthesis | Disease: CU | Group_1: control | Group_2: CU.debut | ea_value: 4.73996585985031 | metabolic_domain: Metabolism | metabolic_subdomain:  Lipid metabolism\n- Ontology: ec00600 | Sample: FECAL | Description: Sphingolipid metabolism | Disease: CU | Group_1: control | Group_2: CU.3.meses | ea_value: 3.42581110492484 | metabolic_domain: Metabolism | metabolic_subdomain:  Lipid metabolism\n- Ontology: ec00633 | Sample: FECAL | Description: Nitrotoluene degradation | Disease: CU | Group_1: control | Group_2: CU.debut | ea_value: 3.36824846707545 | metabolic_domain: Metabolism | metabolic_subdomain:  Xenobiotics biodegradation and metabolism\n- Ontology: ec00603 | Sample: FECAL | Description: Glycosphingolipid biosynthesis - globo and isoglobo series | Disease: CU | Group_1: control | Group_2: CU.3.meses | ea_value: 3.2265242980712 | metabolic_domain: Metabolism | metabolic_subdomain:  Glycan biosynthesis and metabolism\n- Ontology: ec01051 | Sample: FECAL | Description: Biosynthesis of ansamycins | Disease: CU | Group_1: control | Group_2: CU.debut | ea_value: 3.02454964390448 | metabolic_domain: Metabolism | metabolic_subdomain:  Metabolism of terpenoids and polyketides\n- Ontology: ec00940 | Sample: FECAL | Description: Phenylpropanoid biosynthesis | Disease: CU | Group_1: control | Group_2: CU.3.meses | ea_value: 2.81007380924922 | metabolic_domain: Metabolism | metabolic_subdomain:  Biosynthesis of other secondary metabolites\n- Ontology: ec00603 | Sample: FECAL | Description: Glycosphingolipid biosynthesis - globo and isoglobo series | Disease: CU | Group_1: CU.6.meses | Group_2: CU.debut | ea_value: 2.48863122118621 | metabolic_domain: Metabolism | metabolic_subdomain:  Glycan biosynthesis and metabolism\n- Ontology: ec00511 | Sample: FECAL | Description: Other glycan degradation | Disease: CU | Group_1: control | Group_2: CU.3.meses | ea_value: 2.47101554341659 | metabolic_domain: Metabolism | metabolic_subdomain:  Glycan biosynthesis and metabolism\n- Ontology: ec00604 | Sample: FECAL | Description: Glycosphingolipid biosynthesis - ganglio series | Disease: CU | Group_1: control | Group_2: CU.3.meses | ea_value: 2.43028092046414 | metabolic_domain: Metabolism | metabolic_subdomain:  Glycan biosynthesis and metabolism\n- Ontology: ec00531 | Sample: FECAL | Description: Glycosaminoglycan degradation | Disease: CU | Group_1: control | Group_2: CU.3.meses | ea_value: 2.41878343532888 | metabolic_domain: Metabolism | metabolic_subdomain:  Glycan biosynthesis and metabolism\n- Ontology: ec00513 | Sample: FECAL | Description: Various types of N-glycan biosynthesis | Disease: CU | Group_1: control | Group_2: CU.3.meses | ea_value: 2.26618855584615 | metabolic_domain: Metabolism | metabolic_subdomain:  Glycan biosynthesis and metabolism\n- Ontology: ec00130 | Sample: FECAL | Description: Ubiquinone and other terpenoid-quinone biosynthesis | Disease: CU | Group_1: control | Group_2: CU.debut | ea_value: 2.2280943354301 | metabolic_domain: Metabolism | metabolic_subdomain:  Metabolism of cofactors and vitamins\n- Ontology: ec00910 | Sample: FECAL | Description: Nitrogen metabolism | Disease: CU | Group_1: control | Group_2: CU.debut | ea_value: 2.2260120042755 | metabolic_domain: Metabolism | metabolic_subdomain:  Energy metabolism\n- Ontology: ec00940 | Sample: FECAL | Description: Phenylpropanoid biosynthesis | Disease: CU | Group_1: control | Group_2: CU.debut | ea_value: 2.17147153921347 | metabolic_domain: Metabolism | metabolic_subdomain:  Biosynthesis of other secondary metabolites\n- Ontology: ec00513 | Sample: FECAL | Description: Various types of N-glycan biosynthesis | Disease: CU | Group_1: control | Group_2: CU.debut | ea_value: 2.16709357240054 | metabolic_domain: Metabolism | metabolic_subdomain:  Glycan biosynthesis and metabolism\n- Ontology: ec00600 | Sample: FECAL | Description: Sphingolipid metabolism | Disease: CU | Group_1: control | Group_2: CU.debut | ea_value: 2.1566200895128 | metabolic_domain: Metabolism | metabolic_subdomain:  Lipid metabolism\n- Ontology: ec00531 | Sample: FECAL | Description: Glycosaminoglycan degradation | Disease: CU | Group_1: CU.6.meses | Group_2: CU.debut | ea_value: 2.12074460190418 | metabolic_domain: Metabolism | metabolic_subdomain:  Glycan biosynthesis and metabolism
